TRIVASTAL Side Effects

5291678-1 | Abnormal Behaviour, Aggression, Conversion Disorder, Dementia, Disorientation, Hallucination
on Mar 29, 2007 Female patient from FRANCE , 81 years of age, was diagnosed with parkinsonism, hypertension, dementia (What is dementia?) and was treated with Trivastal (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, aggression, conversion disorder, dementia (What is dementia?), disorientation, hallucination. Trivastal dosage: 50 Mg, Bid. During the same period patient was treated with MODOPAR (125 Mg, Qid) (View Modopar Review and Modopar Label ), REQUIP (View Requip Review and Requip Label ), COTAREG (1 Df, Qd) (View Cotareg Review and Cotareg Label ), TRIMETAZIDINE (View Trimetazidine Review and Trimetazidine Label ), ZOLOFT (25 Mg, Qd) (View Zoloft Review and Zoloft Label ), NISISCO (1 Df, Qd) (View Nisisco Review and Nisisco Label ). Patient was hospitalized.

5106768-3 | Eye Pain, Ocular Hypertension
Patient was taking Trivastal (View Usage). Patient had the following side effects: eye pain, ocular hypertension on Jun 01, 2006 from FRANCE Additional patient health information: Male patient , 77 years of age, weighting 149.9 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Trivastal dosage: 150 Mg Daily. During the same period patient was treated with DEPRENYL (5 Mg, Qd) (View Deprenyl Review and Deprenyl Label ), STALEVO 100 (800/600/150 Mg Daily) (View Stalevo 100 Review and Stalevo 100 Label ), MODOPAR (25/100 To 50/200 Mg Daily) (View Modopar Review and Modopar Label ).

5103231-0 | Anorexia, Bacteraemia, Bacteriuria, Bladder Catheterisation, C-reactive Protein Increased, Creatinine Renal Clearance Decreased, Diarrhoea, Fluid Replacement
Adverse event was reported on Sep 04, 2006 by a Male patient taking Trivastal (View Usage) (Dosage: ) . Location: FRANCE , 80 years of age, After Trivastal was administered, patient had the following side effects: anorexia, bacteraemia, bacteriuria, bladder catheterisation, c-reactive protein increased, creatinine renal clearance decreased, diarrhoea, fluid replacement. During the same period patient was treated with SINEMET (4 Df Daily) (View Sinemet Review and Sinemet Label ), STABLON (View Stablon Review and Stablon Label ), COMTAN (View Comtan Review and Comtan Label ). Patient was hospitalized.

5023083-7 | Eye Pain, Glaucoma
on Jun 01, 2006 Male patient from FRANCE , 77 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Trivastal (View Usage). Patient experienced the following unwanted or unexpected effects: eye pain, glaucoma (What is glaucoma?). Trivastal dosage: . During the same period patient was treated with DEPRENYL (View Deprenyl Review and Deprenyl Label ), STALEVO 100 (View Stalevo 100 Review and Stalevo 100 Label ).


4553051-0 | Blood Pressure Orthostatic Decreased, Leukocytosis, Loss Of Consciousness, Malaise, Orthostatic Hypotension
on Jan 06, 2005 Female patient from , 84 years of age, was diagnosed with essential hypertension, dysthymic disorder, myocardial infarction, atrial fibrillation (What is atrial fibrillation?) and was treated with Trivastal (View Usage). Patient had the following side effects: blood pressure orthostatic decreased, leukocytosis, loss of consciousness, malaise, orthostatic hypotension. Trivastal dosage: 50 Mg, Tid. During the same period patient was treated with LASILIX (20 Mg, Qd) (View Lasilix Review and Lasilix Label ), RISPERDAL (Unk, Unk) (View Risperdal Review and Risperdal Label ), NITRIDERM TTS (5 Mg/24hrs) (View Nitriderm Tts Review and Nitriderm Tts Label ), CORDARONE (Unk, Unk) (View Cordarone Review and Cordarone Label ), NISIS (1 Df, Qd) (View Nisis Review and Nisis Label ). Patient was hospitalized.